Good morning, everybody. We're going to get started. We're running a little late.
Thank you for joining us. We have three witnesses this morning. By video conference we have Antoine Charbonneau from CelluForce.
From BioApplied we have Rod Badcock, and back by popular demand, from Cobden Strategies, we have Catherine Cobden.
Why don't we start with the veteran, Ms. Cobden, since know how things work around here.